Moderna's vaccine results add approx. 10% to pre market pricePre market price at 98.9 is above 95 resistance after covid-19 vaccine test results.
Also all time high, which makes it bullish
MRNA trade ideas
MODERNA MRNA Trend Analysis Shows Time To InvestRight now, stocks in companies developing a vaccine against the virus look very attractive to investors. Knowing how to correctly determine the trend and price movement, you can make a profitable investment and get a lot of profit.
We have developed a script that analyzes price movements in real time, taking into account current and past trends, and offers signals to buy company shares MODERNA NASDAQ:MRNA . The script is developed on the basis of the following indicators: Bollinger Bands and Moving Average, Supertrend indicator. Signals are trending and will help complement your trading strategy and more accurately determine entry points. This idea is useful for intraday traders timeframes 1H, 2H, 4H.
MRNA ABCD SHORT SET UP ABCD OR LIGHTNING PATTERN, I AM LOOKING FOR A GAP UP AND RANGE BREAK TO THE DOWNSIDE, POSSIBLY IN PREMARKET
Look for pin bar, double top, engulfing candle, inside bar in zone highlighted
ideally a small gap up and 5 minute to 1hr range break for tight stop entry tp the downside
+92% profit since i called for it and counting ! #MRNABe humble but with confidence to have longevity in the market .
Still has room to go up but for pro's only .. wait for a pull back.
MRNA vaccine data is 94.5% effective!MRNA vaccine data is 94.5% effective! I'm not going to try to develop an analysis on MRNA until people's emotions chill out in the market. This sure seems like ground hogs day, almost identical to last Monday. I'm actually writing this post to share a word of caution. Pay attention and watch out for a bull trap across many sectors, including MRNA stock. The time to get in long on this trade was Friday actually, lol. This morning prices will most likely be the peak for many stocks prices for the rest of the week. Be on the lookout for quick rotations to DIS, SPG & KSS and the like. Remember, after the elation today, we still have record breaking covid19 cases day after day heading into the winter and these vaccines won't be widely distributed for many months. And quite likely, just like last week, they'll be a rotation back to the stay at home stocks by maybe Wednesday. All in all, for me personally, I'm not going to try to catch a falling knife on dropping stocks or time an entry on spiking stocks this morning. I'm going to wait and see, let the euphoria calm down first. If anything, strangles are probably the best candidate on a lot of stocks, due to a lot of price movement. Do your own due diligence, your risk is 100% your responsibility. Consider being charitable with some of your profit to help humankind. Small incremental steps work : If you double a penny for a month it = $5,368,709. Good luck and happy trading friends...
*3x lucky 7s of trading 101*
7pt Trading compass:
Price action, entry/exit
Volume average/direction
Trend, patterns, momentum
Newsworthy current events
Revenue & Earnings
Debt / Cash
Book value, assets
7 Common mistakes:
+5% portfolio trades
Bad risk management
Emotions & Opinions
FOMO : bad timing
Lack of planning & discipline
Forgetting restraint
Obdurate repetitive errors
7 Important tools:
Trading View app!, Brokerage UI
Accurate indicators & settings
Wide screen monitor/s
Trading log (pencil & graph paper)
Big organized desk
Reading books
Sorted watch-list
Checkout my indicators:
Fibonacci VIP - volume
Fibonacci MA7 - price
pi RSI - trend momentum
www.tradingview.com
Moderna Technical Analysis by Omaha trading.This analysis it s designed take a reference on a one years time range. Looking to the performance and the way thing are going on we can assume that Moderna will be able to smash new resistence one next to the others.
MRNA consolidating?MRNA right now is consolidating since is hasn't gone out of the price range $97-102. After this consolidation is over the price is heading down. On the RSI where I circled you can see it is dropping giving a early indication that it was overbought and going to drop in price. PLEASE LEAVE A LIKE OR COMMENT ABOUT WHAT YOU THINK.
$MRNA Moderna $120 Fibonacci target
Moderna has worked off the overbought conditions and
may be ready to take the next wave higher.
Possible Bull-flag breakout after bouncing off previous resistance.
$100 is major psychological resistance.
$120 medium term target.
Stochastic reversing & RSi room to run
Cup and Handle Be SafeAnd another Cup and Handle Pattern
Can be volatile so beware/a very news dependent stock/but no worries for now/according to the media we will all be dead by Christmas
Trade safely
Stop under handle low or mid cup
Just an observation
NV is extremely low. I would imagine smart money bought this a long time ago (NV slacked off to nil at around 18 to 25 dollars)
OBV is high/Positive volume/PV is high
Positive volume represents those who buy on up days which is usually the general public
NV (negative volume represents folks who bought at the low or on down days.) NV kicked in a small amount when price was threatened at 43ish/Smart money does not buy here, but does not mean the trade is over...Just means be careful because they have already made a ton of money and will stick you with the losses at the top. If you got in this a long time ago..then you do not need to be so careful (o:
On-balance volume (OBV) is a technical trading momentum indicator that uses volume flow to predict changes in stock price.
MRNA Moderna vaccine 94.5% effective in Phase 3 trial!This was my previews post about Moderna:
The indicators are still bullish. The price of the stock grew 5X since the beginning of the year.
11/16/2020 Oppenheimer Boost Price Target ➝ $157.00
11/16/2020 Piper Sandler Boost Price Target ➝ $166.00
The traditional method of creating vaccines – introducing a weakened or dead virus, or a piece of one, to stimulate the body's immune system – takes over a decade on average, according to a 2013 study. One pandemic flu vaccine took over eight years while a hepatitis B vaccine was nearly 18 years in the making.
Moderna's vaccine went from gene sequencing to the first human injection in 63 days.
Moderna and BioNTech, for example, are also applying mRNA technology to experimental cancer medicines.
BioNTech's vaccine, for example, must be transported at minus 70 degrees Celsius, though Moderna said on Monday it can ship its candidate in normal refrigerators. (Reuters)
If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
MRNA SnapbackMRNA has had a huge run up on anticipated vaccine news, now that the news has hit the sell off will commence. It is completely beyond the bands of being overextended and overbought. I expect a quick 1-3 day snap back on this down to more Average true range levels around 90 area.
MRNA , MODERNA INC ..its time to sale!! it gonna see a big downturn today !!
and its really difficult to climb back up again ..
don't miss the change today .
MRNA breaking out on vaccines breakthrough.Moderna says its vaccine is 94.5% effective in preventing COVID-19
Reuters
Moderna says its vaccine is 94.5% effective in preventing COVID-19
Julie Steenhuysen and Michael Erman
Mon, November 16, 2020, 7:58 PM GMT+8
By Julie Steenhuysen and Michael Erman
Nov 16 (Reuters) - Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations.
Together with Pfizer Inc's vaccine, also shown to be more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available by the year's end.
Next year, the U.S. government could have access to more than 1 billion doses just from the two vaccine makers, more than needed for the country's 330 million residents.
The vaccines, both built using new technology known as messenger RNA or mRNA, represent powerful new tools to fight a pandemic that has infected 54 million people worldwide and killed 1.3 million. The news also comes at time when COVID-19 cases are soaring, hitting new records in the United States and pushing some European countries back into lockdowns.
"We are going to have a vaccine that can stop COVID-19," Moderna President Stephen Hoge said in a telephone interview.
Moderna's interim analysis was based on 95 infections among trial participants who received either a placebo or the vaccine. Of those, only five infections occurred in those who received the vaccine, which is administered in two shots 28 days apart.
A key advantage of Moderna's vaccine is that it does not need ultra-cold storage like Pfizer's, making it easier to distribute. Moderna expects it to be stable at standard refrigerator temperatures of 2 to 8 degrees Celsius (36 to 48°F) for 30 days and it can be stored for up to 6 months at -20 degrees Celsius.
Nothing to do if the price is hitting highsIt is necessary to wait for the price to fall back to look for an entry or wait for the price to break the high forcefully and then look for a new scenario to continue the upward trend
Moderna w. Too earyl to go Long. Wait 80$ on correction or lowerMonthly
Uptrend due to Covid
Weekly
In range
I do not see strong uptrend confirmation by volume and price formation.
Dai;y
Work with tight SL since it does not look like as strong uptrend.
Open 82 only on pullback
SL 77
TP 95
Moderna leading healthcare outperformanceIn our Monday pre market newsletter, Flight Path, we highlighted the healthcare sector as showing signs of outperformance. We talked about PFE, MRNA and the less popular NVAX. Novavax is still in its “NoGo” trend, but continues to ride the zero line on the oscillator. We will watch that closely.
Both Pfizer and Moderna saw nice jumps in price after the good vaccine news this week and are now in new “Go” trends. PFE has since pulled back a little and we will look to see if it can find support on the GoNoGo Oscillator at the zero line to maintain the trend.
The chart of Moderna, above, has seen a sustained move up since the beginning of the week since re-flagging a “Go” trend.
This recent rally has been accompanied by heavy volume, as we can see in the dark blue of the GoNoGo Oscillator. Momentum is now quite overbought, so we will look to see if price will pause or if it can continue to forge higher.
